BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6779336)

  • 1. Biphasic effects of a potent enkephalin analogue (D-Met2,Pro5)-enkephalinamide and morphine on locomotor activity in mice.
    Székely JI; Miglécz E; Rónai AZ
    Psychopharmacology (Berl); 1980; 71(3):299-301. PubMed ID: 6779336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine and [D-Met2,Pro5]enkephalinamide do not show specific neuroleptic activity.
    Sineger E; Horváth K; Miglécz E; Tarnawa I; Andrási F; Székely JI
    Eur J Pharmacol; 1982 Jun; 80(4):359-68. PubMed ID: 6125401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral activating effects of opiates and opioid peptides.
    Browne RG; Segal DS
    Biol Psychiatry; 1980 Feb; 15(1):77-86. PubMed ID: 6101965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intraventricular morphine and enkephalins on locomotor activity in nondependent, morphine-dependent and postdependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1981 Sep; 218(3):613-20. PubMed ID: 7021799
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.
    Miglécz E; Székely JI; Dunai-Kovács Z
    Psychopharmacology (Berl); 1979 Mar; 62(1):29-34. PubMed ID: 108745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of enkephalins versus opiates on locomotor activity of the horse.
    Nugent TE; Combie JD; Weld JM; Burns P; Tobin T
    Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):405-19. PubMed ID: 7079572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of synthetic enkephalinamides and morphine on abstinence responses in morphine-dependent mice.
    Bhargava HN
    Pharmacol Biochem Behav; 1980 May; 12(5):645-9. PubMed ID: 7190300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of methionine-enkephalin and morphine on spontaneous locomotor activity: antagonism by naloxone.
    Bhargava HN
    Pharmacol Biochem Behav; 1978 Aug; 9(2):167-71. PubMed ID: 714966
    [No Abstract]   [Full Text] [Related]  

  • 10. The in vitro pharmacology of D-Met2,Pro5-enkephalinamide.
    Rónai AZ; Berzétei IP; Bajusz S; Székely JI
    J Pharm Pharmacol; 1981 Aug; 33(8):534-5. PubMed ID: 6115930
    [No Abstract]   [Full Text] [Related]  

  • 11. (D-Met2,Pro5)-enkephalinamide-induced blockade of ovulation and its reversal by naloxone in the rat.
    Köves K; Marton J; Molnár J; Halász B
    Neuroendocrinology; 1981 Feb; 32(2):82-6. PubMed ID: 6782500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of plasma ACTH in the rat following the administration of D-met2-pro5-enkephalinamide.
    Reina RA; Costa G; Scoto GM; Spadaro C; Spampinato S; Ferri S
    Pharmacol Res Commun; 1980 May; 12(5):479-82. PubMed ID: 6108573
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of intraventricular morphine and enkephalins on schedule-controlled behavior in nondependent, morphine-dependent and postdependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1981 Nov; 219(2):344-51. PubMed ID: 7197301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of a potent opioid peptide, (D-Met2, Pro5)-enkephalinamide.
    Jaszlits L; Kósa E; Tardos L; Danitz B; Kauthny K; Székely JI
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):91-103. PubMed ID: 7165424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine-induced hyperthermia: lack of cross-tolerance with enkephalin analogs.
    Clark WG; Bernardini GL
    Brain Res; 1982 Jan; 231(1):231-4. PubMed ID: 6275948
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice.
    Ueda H; Amano H; Shiomi H; Takagi H
    Eur J Pharmacol; 1979 Jun; 56(3):265-8. PubMed ID: 582583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin and growth hormone releasing activity of [D-Met2, Pro5]-enkephalinamide in the rat after systemic administration.
    Locatelli V; Cocchi D; Bajusz S; Spampinato S; Müller EE
    Experientia; 1978 Dec; 34(12):1650-1. PubMed ID: 729748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The behavioural effects of enkephalin analogues injected into the ventral tegmental area and globus pallidus.
    Joyce EM; Koob GF; Strecker R; Iversen SD; Bloom FE
    Brain Res; 1981 Sep; 221(2):359-70. PubMed ID: 7025963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoaminergic modulation of the analgesia induced in rats by (D-Ala2)-met-enkephalinamide (DADA)].
    Garzón J; Moratalla R; del Río J
    Arch Farmacol Toxicol; 1979 Dec; 5(3):177-9. PubMed ID: 546335
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of D-Ala2-met-enkephalinamide and morphine on the activity of choline acetyltransferase and acetylcholinesterase in rat brain.
    Herman ZS; Kowalski J
    Acta Physiol Pol; 1981; 32(3):233-7. PubMed ID: 7304195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.